Dr Kiersten Stead

Managing Partner DCVC Bio


Kiersten is a Managing Partner at DCVC Bio, where she focuses on investing in life science companies that have a deep-tech advantage, principally in therapeutics, agriculture and synthetic biology. Previously, Kiersten was a scientist and holds a Ph.D. in Molecular Biology & Genetics and an MBA in Finance. At DCVC Bio, Kiersten works with entrepreneurs to help them launch their businesses at the foundational stage as well as leading first institutional rounds of funding. She has been involved at the formation or early investment stage of companies like Abcellera (Nasdaq: ABCL), Blue River Technology (acquired by John Deere), Umoja, Mycoworks, Novome and Plexium. Kiersten also serves as a director for several non-profit sports & scientific organizations.